Altium Capital Management focuses on long-term investments in Healthcare companies. We provide growth capital to private and public companies developing novel technologies for human health. Our CEO, Jacob Gottlieb, has over 20 years of healthcare hedge fund, private equity, and venture capital investing experience, developing successful teams of investment professionals and business management staff. Our team includes MD’s, PhD’s, scientific professionals, and experienced fund managers who work together to uncover unique investment insights to produce superior returns in the long term.

Our investment universe is mostly concentrated in therapeutics, within private ventures, small-cap and micro-cap public companies. We look for these companies to have transformative catalysts in the years to come, many of which are raising capital from institutional investors for the first time. Our growth capital supports early-stage ventures in the pre-clinical development phases, with a view to long-term partnerships and multiple rounds of financing into those firms. Altium also helps companies attract additional capital through our network of like-minded investors. Our research and due diligence gives us the confidence to invest long term in promising new technologies.

• Antios Therapeutics Founded in 2018, Antios Therapeutics is a biopharmaceutical company focused on the development of innovative therapies to treat and cure viral diseases

Founded in 2018, Antios Therapeutics is a biopharmaceutical company focused on the development of innovative therapies to treat and cure viral diseases

• Cerevel Therapeutics Cerevel Therapeutics is working relentlessly to find paths through complexity in an effort to bring real progress and new treatment options to people living with a broad range of neuroscience diseases

Cerevel Therapeutics is working relentlessly to find paths through complexity in an effort to bring real progress and new treatment options to people living with a broad range of neuroscience diseases

• Chemomab Therapeutics Chemomab Therapeutics is a clinical-stage biotech company discovering and developing innovative therapeutics for conditions with high unmet need that involve Inflammation and fibrosis

Chemomab Therapeutics is a clinical-stage biotech company discovering and developing innovative therapeutics for conditions with high unmet need that involve Inflammation and fibrosis

• EGenesis At eGenesis, we are committed to ending the global transplant shortage and transforming the treatment of organ failure

At eGenesis, we are committed to ending the global transplant shortage and transforming the treatment of organ failure

• Gemini Therapeutics Gemini Therapeutics is a precision medicine company focused on the development of new therapies for dry AMD

Gemini Therapeutics is a precision medicine company focused on the development of new therapies for dry AMD

• Hummingbird Bioscience We are a clinical-stage biotechnology company with a proprietary and differentiated Rational Antibody Discovery (RAD) platform, developing a broad pipeline of novel, precision therapeutics for the treatment of cancer and autoimmune disease

We are a clinical-stage biotechnology company with a proprietary and differentiated Rational Antibody Discovery (RAD) platform, developing a broad pipeline of novel, precision therapeutics for the treatment of cancer and autoimmune disease

• Hyperfine At Hyperfine, Rothberg and his team of scientists and engineers set out to put MR imaging within reach of every patient regardless of location—in any healthcare facility in any country across the globe

At Hyperfine, Rothberg and his team of scientists and engineers set out to put MR imaging within reach of every patient regardless of location—in any healthcare facility in any country across the globe

• Immunovant Immunovant, Inc
• is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases

Immunovant, Inc is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases

• Ocuphire Pharma Ocuphire Pharma is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders

Ocuphire Pharma is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders

• Palisade Bio Palisade Bio is a late-stage biopharma company advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage

Palisade Bio is a late-stage biopharma company advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage

• Quoin Quoin is an emerging specialty pharmaceutical company dedicated to developing therapeutic products for the treatment of rare and orphan diseases for which no FDA-approved treatments currently exist

Quoin is an emerging specialty pharmaceutical company dedicated to developing therapeutic products for the treatment of rare and orphan diseases for which no FDA-approved treatments currently exist

• Sagimet Biosciences A clinical-stage pharmaceutical company developing novel therapeutics to treat important diseases such as non-alcoholic steatohepatitis (NASH) and various cancers

A clinical-stage pharmaceutical company developing novel therapeutics to treat important diseases such as non-alcoholic steatohepatitis (NASH) and various cancers

• Seelos Therapeutics Seelos intends to become a leading biopharmaceutical company focused on neurological and psychiatric disorders, including orphan indications Seelos intends to become a leading biopharmaceutical company focused on neurological and psychiatric disorders, including orphan indications
• Sonnet BioTherapeutics At Sonnet BioTherapeutics, we are taking the fight directly to cancer

At Sonnet BioTherapeutics, we are taking the fight directly to cancer

• Timber Pharmaceuticals Timber was formed around the collaboration of three companies with demonstrated experience in all phases of drug development and clinical research

Timber was formed around the collaboration of three companies with demonstrated experience in all phases of drug development and clinical research

• Vincerx Pharma Vincerx Pharma is a clinical-stage biopharmaceutical company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer

Vincerx Pharma is a clinical-stage biopharmaceutical company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer

• Yumanity Therapeutics Yumanity Therapeutics is a clinical-stage biopharmaceutical company that is accelerating the revolution in the treatment of neurodegenerative diseases through its transformative scientific foundation and drug discovery platform

Yumanity Therapeutics is a clinical-stage biopharmaceutical company that is accelerating the revolution in the treatment of neurodegenerative diseases through its transformative scientific foundation and drug discovery platform